Hideomi Yamashita | Radiation Oncology | Best Researcher Award

Published on by Award and Honors

 

Best Researcher Award

Hideomi Yamashita
University of Tokyo Hospital, Japan
Hideomi Yamashita
Affiliation University of Tokyo Hospital
Country Japan
Scopus ID 9942829200
Documents 243
Citations 3,998
h-index 36
Subject Area Radiation Oncology
Event Award and Honors
ORCID 0000-0001-9394-9490

Hideomi Yamashita recognizes researchers whose sustained scholarly contributions demonstrate scientific excellence, research productivity, and measurable academic impact. Hideomi Yamashita of the University of Tokyo Hospital has established a distinguished research profile in radiation oncology through extensive peer-reviewed publications, international collaborations, and contributions to evidence-based clinical practice. His publication record, citation performance, and research influence reflect continued engagement in advancing oncological science and improving patient-centered radiotherapy approaches.[1]

Abstract

Hideomi Yamashita has developed an internationally recognized research portfolio in radiation oncology with emphasis on clinical radiotherapy, treatment optimization, cancer management, and translational medical research. His scholarly output demonstrates continuous scientific productivity supported by substantial citation performance and a strong h-index. These indicators illustrate sustained influence within oncology research and support recognition through the Best Researcher Award.[2]

Keywords

Radiation Oncology, Clinical Oncology, Radiotherapy, Cancer Research, Medical Physics, Precision Medicine, Oncology Research, Evidence-Based Medicine, Best Researcher Award, Academic Excellence

Introduction

Radiation oncology remains an essential discipline in modern cancer treatment through the integration of technological innovation, clinical evidence, and multidisciplinary patient care. Academic researchers contribute to improving treatment efficacy, reducing adverse effects, and supporting personalized therapeutic strategies. The scholarly activities of Hideomi Yamashita reflect these objectives through consistent publication, collaboration, and participation in advancing radiation oncology research.[3]

Research Profile

  • Affiliation: University of Tokyo Hospital
  • Country: Japan
  • Research Area: Radiation Oncology
  • Scopus Documents: 243
  • Scopus Citations: 3,998
  • h-index: 36

Research Contributions

The research contributions of Hideomi Yamashita include clinical investigations, radiation treatment planning, patient outcome evaluation, multidisciplinary oncology, and evidence-based therapeutic optimization. His publications have contributed to broader scientific understanding of radiotherapy practices while supporting improvements in clinical decision-making and patient management across oncology settings.[4]

Publications

  • Clinical research articles in radiation oncology journals.
  • Studies on radiotherapy treatment outcomes.
  • Collaborative oncology research involving multidisciplinary clinical teams.
  • Peer-reviewed publications indexed in Scopus and international scientific databases.

Research Impact

With 243 indexed publications, 3,998 citations, and an h-index of 36, the research profile demonstrates measurable academic influence within radiation oncology. Citation indicators suggest that the published work has contributed to ongoing scientific discussion and has been referenced by researchers working across cancer research, radiotherapy, and clinical medicine.

Award Suitability

The Best Researcher Award recognizes scholarly achievement through objective academic indicators together with sustained research quality and international scientific contribution. Hideomi Yamashita’s publication record, citation metrics, institutional affiliation, and continued engagement in oncology research align with the principles commonly considered in academic recognition programs.

Conclusion

Hideomi Yamashita has established a significant scholarly presence in radiation oncology through extensive peer-reviewed publications, sustained citation performance, and continued contributions to clinical cancer research. His academic profile illustrates long-term commitment to scientific advancement, interdisciplinary collaboration, and evidence-based healthcare, supporting recognition within international academic award programs.

References

    1. Scopus author details: Hideomi Yamashita, Author ID 9942829200.
      Scopus. https://www.scopus.com/pages/authors/9942829200
    2. ORCID.Hideomi Yamashita ORCID Record.
      https://orcid.org/0000-0001-9394-9490

    3. Safety and efficacy of moderately hypofractionated radiotherapy after radical prostatectomy: A phase II trial

    4. International Research Award and Honors. Award Information.
      https://awardandhonors.com/

 

Everett Magann | Health Professions | Best Research Article Award

Published on by Award and Honors

Prof. Everett Magann | Health Professions | Best Research Article Award

Research coordinator for MFM Fellowship | University of Arkansas for the Medical Sciences | United States

Dr. Everett F. Magann is a distinguished physician, educator, and researcher in Obstetrics, Gynecology, and Maternal-Fetal Medicine whose career spans both military and academic medicine, shaping the field of women’s health through clinical excellence, education, and groundbreaking research. He began his academic journey with a Bachelor of Science in Biology from Carson Newman College before earning his medical degree from the Medical College of Virginia, followed by residency training in Obstetrics and Gynecology and dual fellowships in Maternal-Fetal Medicine at the University of Mississippi Medical Center. His professional path reflects a rare blend of service and scholarship, having risen to the rank of Captain in the U.S. Naval Reserve while leading departments at major naval medical centers and later advancing academic medicine as a professor at the University of Arkansas for Medical Sciences. A prolific researcher with more than 467 peer-reviewed publications, 11,914 citations by 8,581 documents, and an h-index of 57, his work on amniotic fluid dynamics, high-risk pregnancy management, and ultrasound applications has influenced clinical guidelines and improved maternal and neonatal outcomes worldwide. His leadership has extended to innovations in surgical techniques, cesarean delivery outcomes, and telemedicine applications, ensuring equitable access to maternal care. Recognized with numerous honors for teaching, research, and clinical impact, including prestigious awards from national and international bodies, he continues to inspire future generations of physicians and researchers while shaping global standards in maternal-fetal medicine.

Profile : Scopus 

Featured Publication 

Magann, E. F. (n.d.). Amniotic fluid index as an admission test may increase the incidence of cesarean section in a community hospital. American College of Obstetricians and Gynecologists Meeting.